Juergen Goetz - Fresenius Director
| FSNUY Stock | USD 7.34 0.03 0.41% |
Director
Dr. Juergen Goetz is Chief Legal and Compliance Officer, Labor Relations Director, as well as Member of the Management Board of Fresenius SE Co KGaA since July 1, 2007. From April 1, 2005 until his appointment to the Management Board, Dr. Goetz led the Legal and Insurance Department of Fresenius AG as Senior Vice President and General Counsel. He began his career in 1993 at Hoechst AG, where he held several senior management positions. In 1997, he became head of the Legal Department of Hoechst Marion Roussel AG. In 1999, Dr. Goetz took over the Legal Global Corporationrationrate department of Aventis Pharma AG, the successor company to Hoechst Marion Roussel. since 2007.
| Age | 54 |
| Tenure | 17 years |
| Professional Marks | Ph.D |
| Phone | 49 6172 608 2487 |
| Web | https://www.fresenius.com |
Fresenius Management Efficiency
The company has return on total asset (ROA) of 0.0292 % which means that it generated a profit of $0.0292 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0793 %, meaning that it generated $0.0793 on every $100 dollars invested by stockholders. Fresenius' management efficiency ratios could be used to measure how well Fresenius manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Daren Shaw | The Ensign Group | 61 | |
| Daniel Thomas | Select Medical Holdings | 62 | |
| EPerot Bissell | Acadia Healthcare | 58 | |
| Joan Herman | Encompass Health Corp | 67 | |
| Barry Smith | The Ensign Group | 64 | |
| Russell Carson | Select Medical Holdings | 77 | |
| Thomas Scully | Select Medical Holdings | 63 | |
| Bryan Cressey | Select Medical Holdings | 71 | |
| Yongjun Li | Concord Medical Services | N/A | |
| Chris Gordon | Acadia Healthcare | 44 | |
| William Frist | Select Medical Holdings | 69 | |
| Donald Correll | Encompass Health Corp | 70 | |
| Yvonne Curl | Encompass Health Corp | 65 | |
| Sui Yan | Concord Medical Services | N/A | |
| Ting Lee | Concord Medical Services | 51 | |
| William Grieco | Acadia Healthcare | 64 | |
| Wade Miquelon | Acadia Healthcare | 53 | |
| Tian Ji | Concord Medical Services | N/A | |
| Shangyan Chuang | Concord Medical Services | 35 | |
| Lee Daniels | The Ensign Group | 61 | |
| Andrew Adams | National HealthCare | 72 | |
Management Performance
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 |
Fresenius SE Leadership Team
Elected by the shareholders, the Fresenius' board of directors comprises two types of representatives: Fresenius inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius' management team and ensure that shareholders' interests are well served. Fresenius' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rachel Empey, CFO, Member of the Management Board | ||
| KlausPeter Mueller, Member of the Supervisory Board | ||
| Roland Berger, Member of the Supervisory Board | ||
| Mats Henriksson, Member of the Management Board, CEO Fresenius Kabi | ||
| Michael Albrecht, Member of the Supervisory Board | ||
| Michael Sen, Pres CEO | ||
| Sara Hennicken, Chief Officer | ||
| Ernst Wastler, Member of the Management Board - Fresenius Management SE and CEO of Fresenius Vamed | ||
| Dieter Schenk, Deputy Chairman of the Supervisory Board and Lawyer and Tax Consultant | ||
| Frauke Lehmann, Member of the Supervisory Board | ||
| Matthias Link, Sr Communications | ||
| Markus Georgi, Senior Vice President Investor Relations | ||
| Dario Ilossi, Member of the Supervisory Board, Employee Representative | ||
| Stephan Sturm, CFO of Fresenius Management SE and Member of the Management Board - Fresenius Management SE | ||
| Gregor Zuend, Member of the Supervisory Board | ||
| Konrad Koelbl, Member of the Supervisory Board | ||
| Niko Stumpfoegger, Deputy Chairman of the Supervisory Board, Employee Representative | ||
| Francesco Meo, Member of the Management Board - Fresenius Management SE and CEO of Fresenius Helios | ||
| Bernd Behlert, Independent Member of the Supervisory Board | ||
| Ulf Schneider, Chairman of the Management Board - Fresenius Management SE, CEO of Fresenius Management SE and President of Fresenius Management SE | ||
| Oscar Paco, Member of the Supervisory Board | ||
| Helen Giza, Member SE | ||
| Dieter Reuss, Member of the Supervisory Board | ||
| Sebastian Biedenkopf, HR, Officer | ||
| Gerhard Roggemann, Member of the Supervisory Board | ||
| Stefan Schubert, Member of the Supervisory Board, Employee Representative | ||
| Hauke Stars, Member of the Supervisory Board | ||
| Stefanie Lang, Member of the Supervisory Board | ||
| Iris LoewFriedrich, Member of the Supervisory Board | ||
| Juergen Goetz, Chief Legal and Compliance Officer, Labor Relations Director, Member of the Management Board | ||
| Michael Diekmann, Member of the Supervisory Board | ||
| Rice Powell, Member of the Management Board | ||
| Carla Kriwet, Members SE | ||
| Gerd Krick, Chairman of the Supervisory Board | ||
| Rainer Stein, Member of the Supervisory Board, Employee Representative |
Fresenius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Fresenius a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 43.74 B | |||
| Shares Outstanding | 2.25 B | |||
| Price To Earning | 7.33 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 0.38 X | |||
| Revenue | 37.52 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius SE Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Fresenius Pink Sheet analysis
When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |